BOROSCI124.80

Borosil Scientific Limited

· Capital Goods & Defence
AnnualQuarterly₹ CrorePeersSEJALLTDMcap ₹1,110 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations104.2102.6101.5129.596.0106.9121.3143.2106.8
Other Income2.21.91.92.62.92.12.42.12.7
Total Income106.4104.6103.3132.198.9109.0123.7145.2109.4
Expenses
+ Cost of Materials Consumed34.133.434.941.133.639.241.244.541.0
+ Purchases of Stock-in-Trade2.13.52.85.42.12.43.83.00.4
+ Changes in Inventories1.1-2.4-0.05.5-1.1-2.9-1.52.6-8.1
+ Employee Benefit Expense19.218.619.519.820.120.621.617.922.0
+ Finance Costs0.40.40.40.40.40.20.30.30.3
+ Depreciation & Amortisation4.64.64.64.74.94.84.84.84.9
+ Other Expenses37.834.134.441.036.539.639.043.143.0
Total Expenses99.392.296.4118.196.4103.9109.2116.1103.4
EBITDA9.815.410.016.64.98.017.232.18.5
EBIT5.310.85.411.9-0.03.212.427.33.6
Profit
PBT before Exceptional Items7.012.46.914.02.55.114.629.16.0
+ Exceptional Items0.00.00.00.0-6.60.0-1.90.00.0
Pretax Income7.012.46.914.0-4.15.112.629.16.0
+ Current Tax1.33.22.43.90.03.13.97.41.8
+ Deferred Tax0.70.40.21.50.1-0.8-0.0-5.5-0.1
Tax Expense2.03.62.75.40.12.33.91.91.6
Net Income5.08.84.38.6-4.22.88.727.24.4
+ Net Income — Continuing Ops5.08.84.38.6-4.22.88.727.24.4
+ Other Comprehensive Income-0.0-0.0-0.0-0.1-0.0-0.00.0-0.0-0.1
Total Comprehensive Income5.08.84.28.5-4.22.88.727.24.3
Net Income to Common5.08.84.38.7-4.22.98.727.24.4
Minority Interest-0.00.0-0.0-0.1-0.0-0.00.00.0-0.0
Per Share
Basic EPS0.570.990.480.98-0.470.320.983.060.49
Diluted EPS0.570.990.480.98-0.470.320.983.060.49
Other Comprehensive Income — detail
+ Other Comprehensive Income-0.1-0.0-0.00.0-0.0-0.1
+ Items NOT to be Reclassified to P&L-0.1-0.1-0.1-0.1-0.0-0.00.0-0.0-0.1
+ Tax on Items NOT to be Reclassified-0.0-0.0-0.00.0-0.0-0.0
+ Tax on Items NOT to be Reclassified — alt tag-0.0-0.0-0.0
Comprehensive Income — Owners of Parent5.08.74.38.6-4.22.98.727.24.3
Comprehensive Income — Non-controlling Interests-0.00.0-0.0-0.1-0.0-0.00.00.0-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations0.570.990.480.98-0.470.320.983.060.49
Diluted EPS — Continuing Operations0.570.990.480.98-0.470.320.983.060.49
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit66.968.163.877.461.468.277.793.173.4
Gross Margin %64.2066.3962.9159.7863.9963.8364.0765.0668.79
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)7.012.46.914.02.55.114.629.16.0
− Exceptional Items (reconciliation)0.00.00.00.0-6.60.0-1.90.00.0
Net Income Adj (tax-effected)5.08.84.38.62.42.810.027.24.4
EPS Adj0.570.990.480.980.270.321.133.060.49
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.001.001.001.001.001.00
Paid Up Equity Capital8.98.98.98.98.98.98.98.98.9
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.